key: cord-0839299-ca4pctd3 authors: Sonzogni, Aurelio; Previtali, Giulia; Seghezzi, Michela; Grazia Alessio, Maria; Gianatti, Andrea; Licini, Lisa; Morotti, Denise; Zerbi, Pietro; Carsana, Luca; Rossi, Roberta; Lauri, Eleonora; Pellegrinelli, Alessandro; Nebuloni, Manuela title: Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations date: 2020-07-20 journal: Liver Int DOI: 10.1111/liv.14601 sha: 0ab25ba570e745ff6a63051a301a7ee9e0c23910 doc_id: 839299 cord_uid: ca4pctd3 SARS2‐CoV‐2 breakout in Italy caused a huge number of severely ill patients with a serious increase in mortality. Although lungs seem to be the main target of the infection, very few information are available about liver involvement, possibly evocating a systemic disease. Post‐mortem wedge liver biopsies from 48 patients died from severe pulmonary COVID‐19 disease with respiratory failure were collected from two main hospitals in northern Italy. No patient had clinical symptoms of liver disease or signs of liver failure before and during hospitalization; for each of them liver function tests were available. All liver samples showed minimal inflammation features. Histological pictures compatible with vascular alterations were observed, characterized by increase in number of portal vein branches associated with lumen massive dilatation, partial or complete luminal thrombosis of portal and sinusoidal vessels, fibrosis of portal tract, focally markedly enlarged and fibrotic. SARS‐CoV‐2 was found in 15 of 22 samples tested by in situ hybridization method. Our preliminary results confirm the clinical impression that liver failure is not a main concern and this organ is not the target of significant inflammatory damage. Histopathological findings are highly suggestive for marked derangement of intrahepatic blood vessel network secondary to systemic changes induced by virus that could target not only lung parenchyma but also cardiovascular system, coagulation cascade and endothelial layer of blood vessels. It still remains unclear if the mentioned changes are directly related to virus infection or if SARS‐CoV‐2 triggers a series of reactions leading to striking vascular alterations. pression that liver failure is not a main concern and this organ is not the target of significant inflammatory damage. Histopathological findings are highly suggestive for marked derangement of intrahepatic blood vessel network secondary to systemic changes induced by virus that could target not only lung parenchyma but also car- Bergamo, a city located in north of Italy not far from Milan, became quickly the epicenter of the Italian COVID-19 outbreak. Up to the end of March 2020 more than 9000 people were infected and at least 2500 persons died. Even the area of Milan registered a high number of infected people. To our knowledge, this is the first report of a large series of liver histopathology findings from COVID-19 patients died for respiratory failure. Significant liver clinical involvement has never been observed, neither liver pathology in COVID-19 disease nor clinical-pathological correlations have been reported. Wedge liver sample was obtained post-mortem in 48 SARS-CoV-2positive patients. Testing for HCV antibodies were negative in all patients; one patient was HBsAg positive/ HBV DNA negative. Main demographical and comorbidity data are summarize in Table 1 . Laboratory findings were obtained from clinical charts: we considered the highest value of P p-thrombin time (PT, expressed as international normalized ratio -INR-), D-dimer, aspartate transaminase (AST), alanine transaminase (ALT) and gamma-glutamyl transpeptidase (GGT) and bilirubin reached during the hospital stay. Results are expressed as ratio with the upper reference levels (fold-x-ULR); for platelet count and for Albumin the lowest value was selected. As a result of very short hospital stay, few data are lacking for some patients. Main histological findings obtained from liver biopsies are summarized in Table 2 . It is questionable if the injury needs strictly the ongoing presence of the SARS-Cov-2 virus in tissues or if the reaction targeting endothelium and vessels walls is induced by virus but it is afterwards self-maintaining; further investigations are in progress about this item. Our findings concerning detection of SARS-CoV-2 virus in the liver by ISH method are really intriguing but at present insufficient to support any definite conclusion; we anyway support the hypothesis that viral infection wages a series of pathological processes that proceed disconnect from virus presence. Another main point of interest concerns the evidence in all samples of massive pericytes activation. Active involvement in the recruitment of inflammatory cells in liver injury by pericytes is a well-known mechanism; inflammatory process may induce myofibroblast-like cells transformation of pericytes generating quick and abundant amounts of extracellular matrix proteins and finally leading to vessel wall fibrosis. 13 A crucial question is if any previous chronic asymptomatic condition such as phlebosclerosis noted in variable degree of severity in all biopsies could be a hidden predisposing factor to liver damage partially related to the advanced age of the patients. This precondition may be exacerbated by a further inflammatory injury and pericytes activation induced by viral infection and clearly evident in our material. A promising field of great interest will involve the study of endothelial cell alterations induced by virus infection and its interactions with clotting process. Further studies are required to reach more detailed information on this item. None. A pathological report of three COVID-19 cases by minimally invasive autopsies COVID-19 and liver disease Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy COVID-19 and the liver: little cause for concern Obliterative portal venopathy: portal hypertension is not always present at diagnosis Vascular liver lesions: contemporary views on long-recognized entities Vascular disorders of the liver Obliterative portal venopathy without portal hypertension: an underestimated condition Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 Are liver pericytes just precursors of myofibroblasts in hepatic diseases? Insights from the crosstalk between perivascular and inflammatory cells in liver injury and repair This work is based exclusively on routine file autoptic material and is ethical approval exempt to use anonymous data. The study followed the Italian general rules used for research related to scientific purposes (official regulations n.72-26 /03/2012).